MapLight Therapeutics, Inc. (MPLT)Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
30.05 USD
+1.54
(5.402%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 30.05 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:26 p.m. EDT
MPLT is a biotechnology stock with a recent price surge, but fundamentals show negative earnings and poor profitability. The stock has a strong short-term momentum with a recent 52-week high, but the price-to-book ratio and negative earnings suggest caution. The lack of dividends and high debt-to-equity ratio make it unsuitable for dividend-focused investors. The forecasting model indicates low price direction predictability, suggesting short-term volatility. Long-term investors should consider the company's financial health and potential for future growth, but the current conditions do not support a strong buy recommendation. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.111464 |
| AutoARIMA | 0.112898 |
| MSTL | 0.113387 |
| AutoTheta | 0.113887 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 24% |
| H-stat | 6.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 0.92 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.266 |
| Market Cap | 1,363,459,584 |
| Forward P/E | -8.04 |
| Website | https://www.maplightrx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.5545256 |
| Address1 | 800 Chesapeake Drive |
| All Time High | 31.13 |
| All Time Low | 12.24 |
| Ask | 30.42 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 291,430 |
| Average Daily Volume3 Month | 215,391 |
| Average Volume | 215,391 |
| Average Volume10Days | 291,430 |
| Bid | 29.89 |
| Bid Size | 2 |
| Book Value | 10.412 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 30.05 |
| Current Ratio | 20.006 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 31.13 |
| Day Low | 29.2 |
| Debt To Equity | 1.266 |
| Display Name | MapLight Therapeutics |
| Earnings Timestamp | 1,774,528,200 |
| Earnings Timestamp End | 1,778,761,800 |
| Earnings Timestamp Start | 1,778,761,800 |
| Ebitda | -168,504,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -6.075 |
| Enterprise Value | 1,023,622,848 |
| Eps Current Year | -4.61333 |
| Eps Forward | -3.73667 |
| Eps Trailing Twelve Months | -18.56 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 19.5585 |
| Fifty Day Average Change | 10.491499 |
| Fifty Day Average Change Percent | 0.53641635 |
| Fifty Two Week Change Percent | 55.45256 |
| Fifty Two Week High | 31.13 |
| Fifty Two Week High Change | -1.0799999 |
| Fifty Two Week High Change Percent | -0.03469322 |
| Fifty Two Week Low | 12.24 |
| Fifty Two Week Low Change | 17.81 |
| Fifty Two Week Low Change Percent | 1.4550654 |
| Fifty Two Week Range | 12.24 - 31.13 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,761,571,800,000 |
| Float Shares | 12,740,571 |
| Forward Eps | -3.73667 |
| Forward P E | -8.04192 |
| Free Cashflow | -83,129,872 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 133 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.52266 |
| Held Percent Institutions | 0.52513003 |
| Implied Shares Outstanding | 45,373,033 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-10-27 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; ML-055 for the treatment of neuropsychiatric conditions; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. The company was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California. |
| Long Name | MapLight Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 1,363,459,584 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_605975835 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -161,152,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,274,787,233 |
| Number Of Analyst Opinions | 6 |
| Open | 29.24 |
| Operating Cashflow | -138,136,992 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 617 984 6300 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 30.05 |
| Post Market Time | 1,776,463,443 |
| Previous Close | 28.51 |
| Price Eps Current Year | -6.513733 |
| Price Hint | 2 |
| Price To Book | 2.886093 |
| Profit Margins | 0.0 |
| Quick Ratio | 18.8 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.28571 |
| Region | US |
| Regular Market Change | 1.54 |
| Regular Market Change Percent | 5.40161 |
| Regular Market Day High | 31.13 |
| Regular Market Day Low | 29.2 |
| Regular Market Day Range | 29.2 - 31.13 |
| Regular Market Open | 29.24 |
| Regular Market Previous Close | 28.51 |
| Regular Market Price | 30.05 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 227,694 |
| Return On Assets | -0.34287 |
| Return On Equity | -0.56193 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 42,436,326 |
| Shares Percent Shares Out | 0.0334 |
| Shares Short | 1,418,306 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,355,099 |
| Short Name | MapLight Therapeutics, Inc. |
| Short Percent Of Float | 0.034 |
| Short Ratio | 6.22 |
| Source Interval | 15 |
| State | CA |
| Symbol | MPLT |
| Target High Price | 37.0 |
| Target Low Price | 28.0 |
| Target Mean Price | 32.66667 |
| Target Median Price | 33.0 |
| Total Cash | 305,103,008 |
| Total Cash Per Share | 6.93 |
| Total Debt | 5,802,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -18.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 18.132753 |
| Two Hundred Day Average Change | 11.917246 |
| Two Hundred Day Average Change Percent | 0.6572221 |
| Type Disp | Equity |
| Volume | 227,694 |
| Website | https://www.maplightrx.com |
| Zip | 94,063 |